Reduction of CTRP9, a novel anti-platelet adipokine, contributes to abnormal platelet activity in diabetic animals

Platelet hyper-reactivity is a crucial cause of accelerated atherosclerosis increasing risk of thrombotic vascular events in diabetic patients. The mechanisms leading to abnormal platelet activity during diabetes are complex and not fully defined. The current study attempted to clarify the role of C...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wenqing, Lau, Wayne Bond, Wang, Yajing, Ma, Xinliang, Li, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709932/
https://www.ncbi.nlm.nih.gov/pubmed/26754066
http://dx.doi.org/10.1186/s12933-015-0321-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709932/
https://www.ncbi.nlm.nih.gov/pubmed/26754066
http://dx.doi.org/10.1186/s12933-015-0321-1

Ejemplares similares